Skip to main content

WPI 3659 Pill - pink four-sided, 12mm

Pill with imprint WPI 3659 is Pink, Four-sided and has been identified as Desvenlafaxine Succinate Extended-Release 50 mg (base). It is supplied by Actavis Pharma, Inc.

Desvenlafaxine is used in the treatment of Major Depressive Disorder; Depression and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Desvenlafaxine 50 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3659

Desvenlafaxine succinate extended-release 50 mg (base) WPI 3659
Desvenlafaxine succinate extended-release 50 mg (base) WPI 3659

Desvenlafaxine Succinate Extended-Release

WPI 3659
50 mg (base)
12.00 mm
Prescription only
Drug Class
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
Inactive Ingredients
hypromelloses, microcrystalline cellulose, magnesium silicate, magnesium stearate, silicon dioxide, titanium dioxide, ferric oxide yellow, ferric oxide red, propylene glycol, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.